Skip to main content
Log in

Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy

  • Original Paper
  • Published:
Journal of Molecular Histology Aims and scope Submit manuscript

Abstract

The aim of this study was designed to investigate the possible beneficial effects of the thymoquinone (TQ) in streptozotocine (STZ)-induced diabetes in rats. The rats were randomly allotted into one of three experimental groups: A (control), B (diabetic untreated), and C (diabetic treated with TQ); each group contain ten animals. B and C groups received STZ. Diabetes was induced in two groups by a single intra-peritoneal (i.p) injection of STZ (50 mg/kg, freshly dissolved in 5 mmol/l citrate buffer, pH 4.5). Two days after STZ treatment, development of diabetes in two experimental groups was confirmed by measuring blood glucose levels in a tail vein blood samples. Rats with blood glucose levels of 250 mg/dl or higher were considered to be diabetic. The rats in TQ treated groups were given TQ (50 mg/kg body weight) once a day orally by using intra gastric intubation for 12 weeks starting 2 days after STZ injection. Treatment of TQ reduced the glomerular size, thickening of capsular, glomerular and tubular basement membranes, increased amounts of mesangial matrix and tubular dilatation and renal function as compared with diabetics untreated. We conclude that TQ therapy causes renal morphologic and functional improvement after STZ-induced diabetes in rats. We believe that further preclinical research into the utility of TQ treatment may indicate its usefulness as a potential treatment in diabetic nephropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Allen TJ, Cao Z, Youssef S et al (1997) Role of angiotensin II and bradykinin in experimental diabetic nephropathy: functional and structural studies. Diabetes 46:1612–1618. doi:10.2337/diabetes.46.10.1612

    Article  CAS  PubMed  Google Scholar 

  • Badary OA (1999) Thymoquinone attenuates ifosfamide-induced fanconi syndrome in rats and enhances its antitumour activity in mice. J Ethnopharmacol 67:135–142. doi:10.1016/S0378-8741(98)00242-6

    Article  CAS  PubMed  Google Scholar 

  • Badary OA, Nagi MN, Al-Shabanah OA et al (1997) Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can J Physiol Pharmacol 75:1356–1361. doi:10.1139/cjpp-75-12-1356

    Article  CAS  PubMed  Google Scholar 

  • Badary OA, Abdel-Naim AB, Abdel-Wahab MH et al (2000) The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats. Toxicology 143:219–226. doi:10.1016/S0300-483X(99)00179-1

    Article  CAS  PubMed  Google Scholar 

  • Bendayan M (1985) Alteration in the distribution of type IV collagen in glomerular basal laminae in diabetic rats as revealed by immunocytochemistry and morphological approach. Diabetologia 28:373–378. doi:10.1007/BF00283147

    Article  CAS  PubMed  Google Scholar 

  • Bertani T, Cutillo F, Zoja C et al (1986) Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 30:488–496. doi:10.1038/ki.1986.212

    Article  CAS  PubMed  Google Scholar 

  • Border WA, Yamamoto T, Noble NA (1996) Transforming growth factor b in diabetic nephropathy. Diabetes Metab Rev 12:309–339. doi:10.1002/(SICI)1099-0895(199612)12:4<309::AID-DMR171>3.0.CO;2-A

    Article  CAS  PubMed  Google Scholar 

  • Bunn HF (1891) Non-enzymatic glycosylation of protein: relevance to diabetes. Am J Med 70:325–330. doi:10.1016/0002-9343(81)90769-5

    Article  Google Scholar 

  • Cattell V, Cook T, Moncada S et al (1990) Glomeruli synthetise nitrite in experimental nephrotoxic nephritis. Kidney Int 38:1056–1060. doi:10.1038/ki.1990.312

    Article  CAS  PubMed  Google Scholar 

  • Chakravarty N (1993) Inhibition of histamine release from mast cells by Nigellone. Ann Allergy 70:237–242

    CAS  PubMed  Google Scholar 

  • Desassis JF, Raats CJI, Bakker MAH et al (1997) Antiproteinuric effect of ciclosporin A in adriamycin nephropathy in rats. Nephron 75:336–341. doi:10.1159/000189558

    Article  CAS  PubMed  Google Scholar 

  • El-Abhar HS, Abdallah DM, Saleh S (2003) Gastroprotective activity of Nigella sativa oil and its constituent, thymoquinone, against gastric mucosal injury induced by ischaemia/reperfusion in rats. J Ethnopharmacol 84:251–258. doi:10.1016/S0378-8741(02)00324-0

    Article  CAS  PubMed  Google Scholar 

  • El-Dakhakhny M, Mady N, Lembert N et al (2002) The hypoglycemic effect of Nigella sativa oil is mediated by extrapancreatic actions. Planta Med 68(5):465–466. doi:10.1055/s-2002-32084

    Article  CAS  PubMed  Google Scholar 

  • Erensoy N, Yılmazer S, Ozturk M et al (2004) Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes. Acta Histochem 106:279–287

    CAS  PubMed  Google Scholar 

  • Fararh KM, Shimizu Y, Shiina T et al (2005) Thymoquinone reduces hepatic glucose production in diabetic hamsters. Res Vet Sci 79:219–223. doi:10.1016/j.rvsc.2005.01.001

    Article  CAS  PubMed  Google Scholar 

  • Funabiki K, Makito Y, Yamamoto M et al (1998) Dissociated expression of collagen type IV subchains in diabetic kidneys of KKAy mice. Nephron 80:208–213. doi:10.1159/000045169

    Article  CAS  PubMed  Google Scholar 

  • Haffernan S, James V, Zilkens R et al (1996) Changes of extracellular matrix in a baboon (Papio hamadryas) model of insulin dependent diabetes: studies using electron microscopy and X-ray diffraction technique. Diabetes Res Clin Pract 34:65–72. doi:10.1016/S0168-8227(96)01335-6

    Article  Google Scholar 

  • Hales CN, Randle PJ (1963) Immunoassay of insulin with insulin-antibody precipitate. Biochem J 88:137–146

    CAS  PubMed  Google Scholar 

  • Hasslacher C, Bostedt-Kiesel A, Kempe HP (1992) ACE inhibitor effects on structure and function of the glomerular basement membrane. Klin Wochenschr 69(Suppl. 29):39–44

    CAS  PubMed  Google Scholar 

  • Hedaya SA (1995) Effect of Nigella sativa seed (Black seeds) extract on some haematological and biochemical parameters in rats. Alex J Vet Sci 2:95–99

    Google Scholar 

  • Houghton PJ, Zarka R, de las Heras B et al (1995) Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 61:33–36. doi:10.1055/s-2006-957994

    Article  CAS  PubMed  Google Scholar 

  • Hsu SM, Raine L, Fanger H (1981) Use of avidin–biotin-peroxidase complex (ABC) in immunperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580

    CAS  PubMed  Google Scholar 

  • Huang TW (1980) The nature of basal lamina alterations in human diabetic glomerulosclerosis. Am J Pathol 100:225–238

    CAS  PubMed  Google Scholar 

  • Ihm C-G, Lee GSL, Nast CC et al (1992) Early increased renal procollagen a1 (IV) mRNA levels in streptozotocin induced diabetes. Kidney Int 41:768–777. doi:10.1038/ki.1992.120

    Article  CAS  PubMed  Google Scholar 

  • Ishikawa Y, Watanabe K, Takeno H et al (1998) Effect of the novel oral antidiabetic agent HQL-975 on oral glucose and lipid metabolism in diabetic db/db mice. Arzneim Forsch. Drug Res 48:245–250

    CAS  Google Scholar 

  • Isogai S, Kameyama M, Iso K et al (1998) Protective effects of a small dose of captopril on the reduction of glomerular basement membrane anionic sites in spontaneously hypertensive rats with streptozotocin induced diabetes. J Diabetes Complications 12:170–175. doi:10.1016/S1056-8727(97)00076-7

    Article  CAS  PubMed  Google Scholar 

  • Jensen EB, Guntersen HJG, Osterby R (1979) Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 115:19–33

    CAS  PubMed  Google Scholar 

  • Kanter M (2008) Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochem Res 33:87–96. doi:10.1007/s11064-007-9419-5

    Article  CAS  PubMed  Google Scholar 

  • Kanter M, Meral I, Yener Z et al (2003) Partial regeneration/proliferation of the ß-cells in the islets of Langerhans by Nigella sativa L. in streptozocin-induced diabetic rats. Tohoku J Exp Med 20:213–219. doi:10.1620/tjem.201.213

    Article  Google Scholar 

  • Kanter M, Coskun O, Korkmaz A et al (2004) Effects of Nigella sativa on oxidative stress and ß-cell damage in streptozocin-induced diabetic rats. Anat Rec 279:685–691. doi:10.1002/ar.a.20056

    Article  Google Scholar 

  • Karttunen T, Risteli J, Autio-Harmainen H et al (1986) Effect of age and diabetes on type IV collagen and laminin in human kidney cortex. Kidney Int 30:586–591. doi:10.1038/ki.1986.225

    Article  CAS  PubMed  Google Scholar 

  • Koya D, Haneda M, Nakagawa H et al (2000) Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14:439–447

    CAS  PubMed  Google Scholar 

  • Martin GR, Rohrbach DH, Terranova VP (1983) Structure, function and pathology of basement membranes. In: Wagner BM, Fleischmajer R, Kaufman N et al (eds) Connective tissue disease. Williams and Wilkins, Baltimore, pp 16–30

    Google Scholar 

  • Mauer SM, Steffes MW, Ellis EN et al (1984) Structural–functional relationships in diabetic nephropathy. J Clin Invest 74:1143–1155. doi:10.1172/JCI111523

    Article  CAS  PubMed  Google Scholar 

  • Mohamed A, Shoker A, Bendjelloul F et al (2003) Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor. Biomed Sci Instrum 39:440–445

    CAS  PubMed  Google Scholar 

  • Mohamed A, Afridi DM, Garani O et al (2005) Thymoquinone inhibits the activation of NF-kappaB in the brain and spinal cord of experimental autoimmune encephalomyelitis. Biomed Sci Instrum 41:388–393

    CAS  PubMed  Google Scholar 

  • Montilla P, Tunez I, Munoz MC et al (1997) Hyperlipidemic nephropathy induced by adriamycin: effect of melatonin administration. Nephron 76:345–350. doi:10.1159/000190202

    Article  CAS  PubMed  Google Scholar 

  • Nagi MN, Mansour MA (2000) Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol Res 41:283–289. doi:10.1006/phrs.1999.0585

    Article  CAS  PubMed  Google Scholar 

  • Nagi MN, Alam K, Badary OA et al (1999) Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem Mol Biol Int 47:153–159

    CAS  PubMed  Google Scholar 

  • Osterby R, Gundersen HJG (1980) Fast accumulation of basement membrane material and the rate of morphological changes in acute experimental diabetic glomerular hypertrophy. Diabetologia 18:493–500. doi:10.1007/BF00261706

    Article  CAS  PubMed  Google Scholar 

  • Osterby R, Bangstad HJ, Nyberg G et al (2001) On glomerular structural alterations in type-1 diabetes. Companions of early diabetic glomerulopathy. Virchows Arch 438:129–135. doi:10.1007/s004280000311

    Article  CAS  PubMed  Google Scholar 

  • Park IS, Kiyomoto H, Abboud SL et al (1997) Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46:473–480. doi:10.2337/diabetes.46.3.473

    Article  CAS  PubMed  Google Scholar 

  • Passey RB, Gillum RF, Fuller JB et al (1977) Evaluation and comparison of 10 glucose methods and the reference method recommended in the proposed product class standard (1974). Clin Chem 23:131–139

    CAS  PubMed  Google Scholar 

  • Reddi AS, Ramamurthi R, Miller M et al (1991) Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats. Biochem Med Metab Biol 45:119–131. doi:10.1016/0885-4505(91)90014-C

    Article  CAS  PubMed  Google Scholar 

  • Reddi AS, Nimmagadda VR, Arora R (2001) Effect of antihypertensive therapy on renal artery structure in type 2 diabetic rats with hypertension. Hypertension 37:1273–1278

    CAS  PubMed  Google Scholar 

  • Rohrbach DH, Wagner CW, Star VL et al (1983) Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocininduced diabetic mice. J Biol Chem 258:11672–11677

    CAS  PubMed  Google Scholar 

  • Sen S, Kanter M, Ustundag S et al (2008) Effect of angiotensin-converting enzyme ınhibition and angiotensin II type 1 receptor blockade on streptozotocin-ınduced diabetic nephropathy. Ren Fail 30(10):1023–1033. doi:10.1080/08860220802495248

    Article  PubMed  Google Scholar 

  • Shimomura H, Spiro RG (1987) Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 36:374–381. doi:10.2337/diabetes.36.3.374

    Article  CAS  PubMed  Google Scholar 

  • Steffes MW, Brown DM, Basgen JM et al (1979) Glomerular basement membrane thickness following islet transplantation in the diabetic rat. Lab Invest 41:116–118

    CAS  PubMed  Google Scholar 

  • Striker GE, Eastman RD, Striker LJ (1996) Diabetic nephropathy. Molecular analysis of extracellular matrix and clinical studies update. Nephrol Dial Transplant 11(Suppl. 5):58–61

    CAS  PubMed  Google Scholar 

  • Tamsma JT, Van den Born J, Bruijn JA et al (1994) Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37:313–320. doi:10.1007/BF00398060

    Article  CAS  PubMed  Google Scholar 

  • Tarsio JF, Reger LA, Furcht LT (1988) Molecular mechanisms in basement membrane complications of diabetes: alterations in heparin, laminin and type IV collagen association. Diabetes 37:532–539. doi:10.2337/diabetes.37.5.532

    Article  CAS  PubMed  Google Scholar 

  • Venkatesan N, Venkatesan P, Karthikeyan J et al (1997) Protection by taurine against adriamycin-induced proteinuria and hyperlipidemia in rats. Proc Soc Exp Biol Med 215:158–164

    CAS  PubMed  Google Scholar 

  • Wolf G, Ziyadeh FN (1997) The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 29:153–163. doi:10.1016/S0272-6386(97)90023-8

    Article  CAS  PubMed  Google Scholar 

  • Zima T, Tesar V, Stipek S et al (1997) The influence of cyclosporin on lipid peroxidation and superoxide dismutase in adriamycin nephropathy in rats. Nephron 75:464–468. doi:10.1159/000189586

    Article  CAS  PubMed  Google Scholar 

  • Ziyadeh FN (1993) Renal tubular membrane and collagen type IV in diabetes mellitus. Kidney Int 43:114–120. doi:10.1038/ki.1993.19

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Kanter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanter, M. Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy. J Mol Hist 40, 107–115 (2009). https://doi.org/10.1007/s10735-009-9220-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10735-009-9220-7

Keywords

Navigation